Hygiena 2019, 64(1):10-15 | DOI: 10.21101/hygiena.a1706

Principles of optimal antisclerotic nutrition

Igo Kajaba1, Manon Genčíková1, Ladislav Staruch2, Eva Hybenová2, Vladimír Bencko3, Jan Ševčík4, Petr Šíma5, Bohumil Turek4
1 CarnoMed, medicínske centrum, Bratislava, Slovenská republika
2 Slovenská technická univerzita, Fakulta chemickej a potravinárskej technológie, Ústav potravinárstva a výživy, Bratislava, Slovenská republika
3 Univerzita Karlova, 1. lékařská fakulta, Ústav hygieny a epidemiologie a Všeobecná fakultní nemocnice, Praha, Česká republika
4 Společnost pro výživu, Praha, Česká republika
5 Akademie věd ČR, Mikrobiologický ústav, Praha, Česká republika

The author's team from the Slovak Republic and the Czech Republic presents an overview of the preventive role of selected nutritional factors and foods in antisclerotic nutrition. Attention is also drawn to the nutrition risk components involved in the initiation of atherosclerotic cardiovascular diseases. The results of 2 dietary tests in subjects with primary combined hyperlipoproteinemia are presented. In the first test were administered PUFA n-3 in the amount of 2.0 g/day 3 times in a week (in the form of mackerel in the amount of 150 g/day). Therein a total of 37 subjects (average age 39.3 years) underwent testing after 42 days. Significant reductions in triacylglycerolemia, decrease in cholesterolemia and elevation of HDL-cholesterol were demonstrated. Another 4 week dietary test with apple pectin in a daily dose of 20 g and vitamin C in the amount of 300 mg administered to 27 subjects (average age 46.5 years) with primary combined hyperlipoproteinemia was realised. A significant hypolipidemic effect has been confirmed: reduction of cholesterolemia, stable level of HDL-cholesterol, and decrease of triacylglyrolemia and LDL-cholesterol. There was determined an increased cholesterol waste and its coprostanol derivative in the stool, which corresponds to the binding of pectin and cholesterol in the intestine. Presented is also a significant piece of knowledge about the regular consumption of milk and milk products in the prevention of the prevalence of metabolic syndrome.

Keywords: atherosclerosis, metabolic syndrome prevention, nutrition

Received: November 2018; Accepted: January 14, 2019; Published: February 28, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kajaba I, Genčíková M, Staruch L, Hybenová E, Bencko V, Ševčík J, et al.. Principles of optimal antisclerotic nutrition. Hygiena. 2019;64(1):10-15. doi: 10.21101/hygiena.a1706.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Turek B, Šíma P, Kajaba I, Ševčík J. Co je nového v prevenci aterosklerózy. Výživa a zdraví. 2017;12-9.
    2. Mendez MA, Popkin BM, Jakszyn P, Berenguer A. Adherence to a Mediterranean Diet is associated with reduced 3-year incidence of obesity. J Nutr. 2006;136(11):2934-8. Go to original source... Go to PubMed...
    3. American Heart Association. Nutrition committee scientific statement: Diet and lifestyle recommendations revision. Circulation. 2006;114(1):82-96. Go to original source...
    4. Šíma P, Turek B, Bencko V. Aterokleróza a imunita; Arterie jako terciární lymfoidný orgán? Prakt Lek. 2018;98(2):65-8.
    5. Šíma P, Turek B, Ševčík J, Kajaba I. Imunita při nádorových chorobách a ateroskleróze. Výživa a zdraví. 2018;18-22.
    6. EFSA NDA. Scientific Opinion on dietary reference values for fats, including saturated, monounsaturated and polyunsaturated fatty acids, trans- fatty acids and cholesterol. EFSA J. 2010;8(3):107. Go to original source...
    7. Kajaba I, Štencl J, Ginter E, Šašinka AM a kol. Nové Odporúčané výživové dávky (OVD) obyvateľstva SR (9. revízia) z r. 2015 - preventívne koncipované na ďalšie obdobie. "Výživa a zdraví 2015". Praha: ČLS J.E.Purkyně - SH a KM, Společnost pro výživu, 2015. s. 75-87.
    8. Kris-Etherton PM, Harris WS, Appel LJ; AHA Nutritiom committee. American Heart Association. Omega-3 fatty acids and cardiovascular disease: New recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23(2):151-2. Go to original source... Go to PubMed...
    9. Cefalu WT, Cannon ChP. Cardiometabolic risk. New York: Informa Healthcare USA; 2007. Go to original source...
    10. Kajaba I, Simoncic R, Frecerova K, Belay G. Clinical studies on the hypolipidemic and antioxidant effects of selected natural substances. Bratisl Medical J. 2008;109(6):267-72.
    11. Šimek J. Vliv hlavních živin na tvorbu eikosanoidů - vztah ke komplikacím obezity. Výživa a zdraví. 1999;27-32.
    12. Svěchová H. Effect of n-3 polyunsaturated fatty acids on protein involved in signaling pathways of cardioprotection. Praha: UK, Přírodovědecká fakulta; 2009.
    13. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003;108(2):155-60. Go to original source... Go to PubMed...
    14. Szabóová E. Manažment kardiovaskulárneho rizika u diabetikov v svetle aktuálnych odporúčaní. Forum Diab. 2017;6(3):121-34.
    15. Filipová S. Liečba statínmi pri artériovej hypertenzii; Endotelová dysfunkcia. Nové trendy v prevencii aterosklerózy. Kompendium Med. 2010;7:5-8.
    16. Dlouhý P, Anděl M, Tvrzická E, Žák A. Trans-formy mastných kyselin a jejich rizika pro zdraví. Výživa a zdraví. 1998;45-54.
    17. Murín J, Pernický M, Wawruch M. Je možné zlepšiť primárnu prevenciu ischemickej choroby srdca? A akým spôsobom? AtheroRev. 2016;1(3):116-9.
    18. Battista P, Di Primio R, Di Luzio A, et al. Correlations between dietetic fibre and serum levels of total cholesterol and HDL-cholesterol. Boll Soc Ital Biol Sper. 1983;59(1):83-6. Go to PubMed...
    19. Kajaba I, Hrušovský Š, Gazdíková K a kol. Metabolické poruchy - možnosti ich korekcie prírodnými látkami vo výžive. In: Jurkovičová J, Štefániková Z. ŽPaZ. Bratislava: ÚVZ SR, ÚH LF UK; 2014. s. 123-33.
    20. Ginter E. Cholesterol: vitamin C its transformation to bile acids. Science. 1973;179(5):702-4. Go to original source... Go to PubMed...
    21. Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after Acute coronary syndromes. N Engl J Med. 2015;372(25):2387-97. Go to original source... Go to PubMed...
    22. Ginter E. Chronic vitamin C deficiency increases the risk of cardiovascular diseases. Bratislava Medical J. 2007;108(9):417-21.
    23. Myint PK, Luben RN, Welch AA, Bingham SA. Plasma vitamin C concentrations predict risk of incident stroke over 10y in 20649 participans of the European Prospective Investigation in to Cancer-Norfolk propektive population study. Am J Clin Nutr. 2008;87(1):64-9. Go to original source... Go to PubMed...
    24. Sauvaget C, Nagano J, Allen N. Vegetable and fruit intake and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Stroke. 2003;34(10):2355-60. Go to original source... Go to PubMed...
    25. King JC, Blumberg J, Ingwersen L, Jenab M. Tree nuts and peanuts as components of a healthy diet. J Nutr. 2008;138(9):1736S-40S. Go to original source... Go to PubMed...
    26. Kris-Etherton PM, Hu FB, Ros E, Sabate J. The role of tree nuts and peanut in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138:1746S-51S. Go to original source... Go to PubMed...
    27. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia and art. hypertension. Arch Intern Med. 1989;149(7):1514-20. Go to original source...
    28. Mille M. Epidemiology of triglyceride as coronary artery disease risk factor. Clin Cardiol Med. 1999;22(Suppl 2):11-6. Go to original source... Go to PubMed...
    29. Reaven G.M. Banting lecture 1988: Role of insulin resistence in human disease (Syndrome- X). Diabetes. 1988;37:1595-607. Go to original source... Go to PubMed...
    30. Reaven G.M. Syndrome - X: 10 years after. Drugs 1999;58(Suppl 1):19-20. Go to original source... Go to PubMed...
    31. Elwood PC. Time to value milk. Int J Epidemiol. 2005;34(5):1160-2. Go to original source... Go to PubMed...
    32. Elwood PC, Pickering JE, Fehily AM. Milk and dairy consumption, diabetes and the metabolic syndrome: The Caerphilly prospective study. J Epidemiol Comm Health. 2007;61(8):695-8. Go to original source... Go to PubMed...
    33. Enas EA, Senthilkumar A, Chennikkara H, Bjurlin MA. Prudent-diet and preventive nutrition from pediatrics to geriatrics: Current knowledge and practical recommendations. Indian Heart J. 2003;55(4):310-38.

    Return to the content